Immunological analysis of liver cancer stem cells and immunotherapy
| Project/Area Number |
21590841
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKEHARA Tetsuo 大阪大学, 医学系・研究科, 准教授 (70335355)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 肝癌 / 癌幹細胞 / 癌免疫 |
|---|
| Research Abstract |
We analyzed the immunological property of liver cancer stem cells(CSC). CD133+ CSC cells express higher MMP-2 and ADAM9 which resulted in increasing the ability of invasion, the production of VEGF and decreasing NK sensitivity of the liver CSC. FGF-2 enhances the NK sensitivity of HCC cells and serum FGF-2 levels decrease along the progression of chronic liver disease.α-fetoprotein inhibited the production of interleukin-12 of dendritic cells which resulted in the inhibition of activation of NK cells.
|
Report
(4 results)
Research Products
(122 results)
